Through the service, physicians will be able to send a patient’s tumor tissue to Quest Diagnostics for genetic sequencing. IBM Watson will then analyze the genetic alterations in the tissue, and Memorial Sloan Kettering will conduct a research-based analysis through its oncology precision medicine database to determine potential treatment options.
Through the collaboration, the partners hope to give physicians “the ability to create a unique, personalized approach for their patients,” according to IBM.
More articles on health IT:
USAID funds technology platform to identify Zika “cold spots” in Guatemala
Eastern Oklahoma VA, local healthcare organizations to share veteran health information through eHealth Exchange
Mobile health app revenue expected to grow through 2020: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.